An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension

Abstract

Pulmonary arterial hypertension is a progressive fatal disease characterized by pathological pulmonary artery remodeling. Here the authors show that the dysregulation of the activin A-bone morphogenetic protein receptor type 2 link in the endothelium is involved in the progression of pulmonary hypertension.